Last Updated 11/26/14

Combined agenda for the 2014 World Stem Cell Summit and RegMed Capital Conference.

Tuesday, December 2, 2014

9:00a - 10:00a - Offsite Event  -

Pre-Summit Event: Stem Cells — Their Biology and Promise for Regenerative Medicine

This special lecture by Elaine Fuchs, PhD, Rockefeller University is FREE and open to the general public as part of The Stem Cell and Regenerative Medicine Public Education Day, presented by The University of Texas Health Science Center at San Antonio and the World Stem Cell Summit.

LOCATION: 

Holly Auditorium
7703 Floyd Curl Drive
San Antonio, Texas 78229

For more information, click here.

Presenter

 Elaine Fuchs, PhD, Rockefeller University

12:15p - 5:15p Offsite Tour - Meet in Lobby  -

World Stem Cell Summit San Antonio Research Resource Tour

NOTE:  To participate in this event, you must register in advance and must be a paid registrant for the World Stem Cell Summit or the RegMed Capital Conference.

Tour three of San Antonio’s science powerhouses!  Visit world-class facilities with a breadth of resources for potential partners.  On the day before the World Stem Cell Summit begins, December 2, 2014, a pre-registered group will tour BioBridge Global, the Southwest National Primate Research Center (SNPRC) at the Texas Biomedical Research Institute and the Southwest Research Institute (SwRI).  This tour includes Lunch.

For a detailed tour description and to register, click here:
http://worldstemcellsummit.com/research-resource-tour/

1:00p - 4:00p - Offsite Event  -

Pre-Summit Event: Public Education Day

Leading scientists, doctors and patient advocates will present workshops geared toward the general public at The Stem Cell and Regenerative Medicine Public Education Day, presented by The University of Texas Health Science Center at San Antonio and the World Stem Cell Summit.

LOCATION: 
Holly Auditorium
7703 Floyd Curl Drive
San Antonio, Texas  78229

For more information, click here.

 David L. Bales, Texans for Stem Cell Research

 Tiziano Barberi, PhD, Texas Biomedical Research Institute

 Marcel M. Daadi, PhD, Texas Biomedical Research Institute

 Michael R. Davis, MD, FACS, United States Army Institute of Surgical Research

 Cesar O. Freytes, MD, FACC, University of Texas Health Science Center in San Antonio

 Teja Guda, PhD, University of Texas at San Antonio

 Brian P. Hermann, PhD, University of Texas at San Antonio

 Peter J. Hornsby, PhD, University of Texas Health Science Center at San Antonio

 Jon Hudson, GenCure Marrow Donor Program

 Erzsebet Kokovay, PhD, University of Texas Health Science Center at San Antonio

 Donna Lehman, PhD, University of Texas Health Science Center at San Antonio

 Bettie Sue Masters, PhD, D.Sc., MD (Hon.), University of Texas Health Science Center at San Antonio

 John R. McCarrey, PhD, University of Texas at San Antonio

 Mary Pat Moyer, PhD, INCELL Corporation

 Pei Wang, PhD, University of Texas Health Science Center at San Antoni

6:30p - 8:00p  -Sazo’s

Reception

WSCS / RMCC Speaker Reception – By Invitation Only

Reception for Speakers at the World Stem Cell Summit and the RegMed Capital Conference – By Invitation Only!

Wednesday, December 3, 2014

8:00a - 8:30a  -Salon E-F

Welcome Overview

Partner Greetings

Moderator

 Bernard Siegel, JD, Genetics Policy Institute

Speakers

 William L. Henrich, MD, MACP, The UT Health Science Center at San Antonio

 Norio Nakatsuji, DSc, Institute for Integrated Cell-Material Science (iCeMS), Kyoto University

 Linda Myers, ASCP, MT, SBB, CQA (ASQ), BioBridge Global

 Andre Terzic, MD, PhD, Center for Regenerative Medicine, Mayo Clinic

8:30a - 9:30a  -Salon E-F

Plenary Keynote

Regenerative Medicine: Current Concepts and Changing Trends

Presenter

 Anthony Atala, MD, Wake Forest University Medical Center

9:30a - 10:30a  -Salon A-B

Track Keynote

Discovery

(Bio)Banking on the Future of RegMed: Building Organs is Just Part of it

Presenter

 Doris A. Taylor, PhD, FAHA, FACC, Texas Heart Institute at St. Luke's Episcopal Hospital

9:30a - 10:30a  -Salon C-D

Panel Discussion

Translation & Clinical Trials

Leading Neurological Clinical Trials from Academia and Industry

Moderator

 Thomas P. Zwaka, MD, PhD, Icahn School of Medicine at Mt. Sinai

Speakers

 Martin McGlynn, StemCells, Inc.

 Nathan P. Staff, MD, PhD, Mayo Clinic

9:30a - 10:30a  -Conference Room 1-2

Panel Discussion

Innovation Showcase

Missing Link for Successful Trials: The Non-human Primate Imperative

Moderator

 Marcel M. Daadi, PhD, Texas Biomedical Research Institute

Speaker

 Brian P. Hermann, PhD, University of Texas at San Antonio

 Peter J. Hornsby, PhD, University of Texas Health Science Center at San Antonio

 John R. McCarrey, PhD, University of Texas at San Antonio

9:30a - 10:30a  -Conference Room 3-4

Panel Discussion

Reg Med Capital Conference

RegMed & Cell Therapy- Multi-Billion Dollar Industries with Unlimited Potential

Moderator

 Gregory A. Bonfiglio, Proteus Venture Partners

Speakers

 Gregory A. Bonfiglio, Partner, Proteus Venture Partners

 Jane C. Andrews, PhD, Frost & Sullivan

 Chris Mason, MBBS, PhD, FRCS, University College London

9:30a - 10:30a  -Conference Room 13-14

Track Keynote

Regenerative Services & Restorative Medicine

Tissue Repair and Regeneration Using Adipose Tissue as a Biological Resource: Past, Present and Future

Presenter

 Adam J. Katz, MD, FACS, University of Florida College of Medicine

9:30a - 10:30a  -Conference Room 17-18

Panel Discussion

Hot Topics & Future Trends

Global Regulation of Stem Cell Therapies

Moderator

 Rosario Isasi, JD, MPH, McGill University & Genome Quebec Innovation Centre

Speakers

 Timo Faltus, Translational Centre for Regenerative Medicine (TRM)

 Donald W. Fink, Jr., PhD, Center for Biologics Evaluation and Research / US FDA

 Yoji Sato, PhD, National Institute of Health Sciences

10:30a - 11:00a  -Salon G-M

Break

Exhibits Open / Morning Break

11:00a - 12:30p  -Salon A-B

Panel Discussion

Discovery

Exciting Discoveries in Pluripotency

Moderator

 Don L. Gibbons, California Institute forr Regenerative Medicine

Speakers

 Tiziano Barberi, PhD, Texas Biomedical Research Institute

 Norio Nakatsuji, DSc, Institute for Integrated Cell-Material Science (iCeMS), Kyoto University

 Thomas P. Zwaka, MD, PhD, Icahn School of Medicine at Mount Sinai

11:00a - 12:30p  -Salon C-D

Concurrent Session

Translation & Clinical Trials

US Military Investment in Regenerative Medicine

Over the past decade, in the shadow of Operation Iraqi Freedom and Operation Enduring Freedom, DoD has taken a leading role in funding regenerative medicine research. From the Armed Forces Institute of Regenerative Medicine to Congressional Directed funds as well as Service specific programs, the goal has been to advance the restoration of wounded service members that have suffered devastating combat injuries. The full spectrum of advances in regenerative medicine as well as complex reconstructive surgery, including reconstructive transplantation, have been leveraged to facilitate the best possible long term outcomes for our warriors. In the face of continued instability in our world, DoD will continue to require intramural and extramural innovation to advance combat casualty care. DoD funding mechanisms represent unique opportunities to advance the science of regenerative medicine while also striving toward the noble goal of optimizing care for our wounded service members.

Moderator

 Michael R. Davis, MD, FACS, United States Army Institute of Surgical Research

Speakers

 Brian Pfister, PhD, MBA, US Army Medical Research and Materiel Command

 Debra Niemeyer, PhD, 59th Medical Wing Joint Base San Antonio

 Anthony J. Windebank, MD, Mayo Clinic

 Michael J. Yaszemski, MD, PhD,, Mayo Clinic

11:00a - 12:30a  -Conference Room 1-2

Panel Discussion

Innovation Showcase

Tools of the Trade: Crucial Technologies for the Core Lab (supported by Bioscience Technology)

Moderator

 Tim Studt, Advantage Media Group

Speakers

 Sunita D'Souza, PhD, Mount Sinai School of Medicine

 Tenneille Ludwig, PhD, WiCell

 Ian McNiece, PhD, MD Anderson Cancer Center

 Mark Tomishima, PhD, Memorial Sloan-Kettering Cancer Center

11:00a - 12:30p  -Conference Room 3-4

Panel Discussion

Reg Med Capital Conference

Company Presentations – Session 1

Moderator

 Robert E. Margolin, MBS, MBA, Cognate BioServices, Inc.

Speakers

 Michael McCullough, MD, RegenMed Systems

 Flagg Flanagan, DiscGenics

 Craig Carlson, Stemedica USA

 Kenneth L. Harris, Cesca Therapeutics

 Michael D. West, PhD, BioTime, Inc.

11:00a - 12:30p  -Conference Room 13-14

Panel Discussion

Regenerative Services & Restorative Medicine

Adipose Tissue and SVF

Adipose tissue until recently was considered to be poor grafting material in tissue reconstruction. Pioneering work by Sidney Coleman MD on processing techniques for fat grafting led to its increased use. As adipose tissue grafting became widespread its regenerative properties came to the fore as surgeons noticed unexpected skin rejuvenation, scar resolution, and most remarkably reversal of hitherto intractable conditions such as radiation fibrosis. In the late ’90s under the direction of William Futrell MD at the University of Pittsburgh, Adam Katz MD first isolated and recognized the abundant presence of MSC’s (mesenchymal stem cells) in adipose tissue, thus providing the key to understanding the regenerative potential of Adipose tissue which is contained in its Stromal Vascular Fraction (SVF). Building on this foundation, Peter Rubin MD has created a powerhouse engine of academic research and the central nexus for Adipose tissue and SVF science at the University of Pittsburgh. Bringing SVF technologies to market is a arduous process but William Cimino PhD, CEO of GID has proven autologous SVF therapy is not only market ready, but already being deployed in several countries successfully.

Moderator

 Ricardo Luis Rodriguez, MD, Cosmeticsurg

Speakers

 William W. Cimino, PhD, The GID Group, Inc.

 Adam J. Katz, MD, FACS, University of Florida College of Medicine

 J. Peter Rubin, MD, University of Pittsburgh

11:00a - 12:30p  -Conference Room 17-18

Concurrent Session

Hot Topics & Future Trends

Regenerative Medicine: A New Era of Discovery and Innovation (supported by Mary Ann Liebert, Inc.)

Moderator

 John Sterling, Genetic Engineering & Biotechnology News (GEN)

Speakers

 Marie Csete, MD, PhD, Huntington Medical Research Institute

 Aubrey de Grey, PhD, Sens Foundation

 Jeanne F. Loring, PhD, The Scripps Research Institute

 Henry McCusker, Scimitar Equity

 Graham Parker, PhD, Wayne State University School of Medicine

12:30p - 2:30p  -Salon G-M

Conversations with Experts – Lunch

2:30p - 3:30p  -Salon A-B

Concurrent Session

Discovery

Using Stem Cells and Other Advanced Therapies to Tame Cancer

Speakers

 William K. Decker, PhD, Baylor College of Medicine

 LuZhe Sun, PhD, University of Texas Health Science Center at San Antonio

 Avi Treves, PhD, Sheba Medical Center

2:30p - 3:30p  -Salon C-D

Concurrent Session

Translation & Clinical Trials

Stem Cells Translation: From the Bench to the Clinic- Supported by AlphaMed Press

The Session Objectives are to detail the progress and future aspirations for translating stem cell therapies to the clinic.  Having adequate translation requires the development of infrastructure, resources, and technology to efficiently run clinical trials, evaluate safety and efficacy for new therapies, and develop a process to ensure rapid regulatory approval for new therapies with regulatory agencies. This should also enable commercialization of medical devices, reagents, and other products required for cell therapies through the development and dissemination of innovative methods and procedures for regenerative medicine based products.  A panel of experts will discuss these important topics in an interactive format.

Moderator

 Anthony Atala, MD, Wake Forest University Medical Center

Speakers

 Rick Blume, Excel Venture Management

 Geoff Crouse, MBA, MPH, Cord Blood Registry

 C. Randal Mills, PhD, California Institute for Regenerative Medicine (CIRM)

2:30p - 3:30p  -Conference Room 1-2

Concurrent Session

Innovation Showcase

Creative Ways to Organize, Finance & Launch Manufacturing Initiatives (Sponsored by Stemedica, Inc.)

The “Creative Ways To Organize, Finance & Launch Manufacturing Initiatives” session will explore the innovative aspects of how technology, financing and collaboration are rapidly changing the strategies and approaches to manufacturing in our space.  These innovative manufacturing approaches are beginning to equip our industry with the necessary expertise, resources and infrastructure to produce cellular products at scale while maintaining potency, consistency and safety profiles. The ultimate result will be a more cost effective method to bring cellular therapies to market with a higher clinical trial to commercialization success ratio. The renowned panelists will share their experience and perspective on the current state of manufacturing as well as provide insight on the future in a dynamic and collaborative panel discussion. 

Moderator

 David M. McGuigan, Stemedica, Inc.

Speakers

 Steven Lynum, Panasonic Healthcare Corporation

 Chris Mason, MBBS, PhD, FRCS, University College London

 Gerald W. Parker, DVM, PhD, MS, Texas A&M Health Science Center

2:30 - 3:30  -Conference Room 3-4

Concurrent Session

Reg Med Capital Conference

Protecting Your Intellectual Property: The Foundation to Raising Capital

While patents form the core asset of most firms in the life science field, in †he past few years they’ve been scrutinized by the government and the US Supreme Court.  The panel will look at the current US patent landscape including recent life science patent decisions by the US Supreme Court with an emphasis on their impact in the stem cell field. The panel will also consider what’s presently patentable in the stem cell field in the US and in Europe and look at some tools for evaluating stem cell patent portfolios.”

Moderator

 S. Peter Ludwig, Fish & Richardson, P.C.

Speakers

 S. Peter Ludwig, Fish & Richardson P.C.

 Robin A. Chadwick, Ph.D., J.D., Schwegman Lundberg Woessner P.A.

 Maria Luisa Palmese, Kenyon & Kenyon LLP

 Robert C. Sullivan, Jr., Fish & Richardson P.C.

2:30p - 3:30p  -Conference Room 13-14

Concurrent Session

Regenerative Services & Restorative Medicine

Plastic Surgery and the Clinical Use of Stem Cells

Moderator

 Ricardo Luis Rodriguez, MD, Cosmeticsurg

Speakers

 Michael R. Davis, MD, FACS, United States Army Institute of Surgical Research

 Jaime R. Garza, MD, DDS, FACS, University of Texas Health Science Center at San Antonio

 Jeffrey R. Janus, MD, Mayo Clinic

 J. Peter Rubin, MD, University of Pittsburgh

2:30p - 3:30p  -Conference Room 17-18

Concurrent Session

Hot Topics & Future Trends

Regenerative Medicine and Stem Cell Institutes: The Best Practices for Achieving Success

Moderator

 Jonathan Thomas, PhD, JD, California Institute for Regenerative Medicine

Speakers

 Jan A. Nolta, PhD, Professor, Stem Cell Program and Institute for Regenerative Cures, UC Davis

 Brock C. Reeve, Harvard Stem Cell Institute, Polliwog Regenerative Medicine Fund

 Andre Terzic, MD, PhD, Center for Regenerative Medicine, Mayo Clinic

3:30p - 4:00p  -Salon G-M

Break

Afternoon Break – Exhibits Open

4:00p - 5:00p  -Salon A-B

Concurrent Session

Discovery

The Science of Perinatal Stem Cells: Cord Blood, Placental Cells and Wharton’s Jelly

Moderator

 Rasul Chaudhry, PhD, Oakland University

Speakers

 Stewart E. Abbot, PhD, Celgene Cellular Therapeutics

 Kyle J. Cetrulo, AuxoCell Laboratories, Inc.

 Raphael Gorodetsky, PhD, Hadassah Medical Center

4:00p - 5:00p  -Salon C-D

Concurrent Session

Translation & Clinical Trials

Innovative Clinical Trials: Academic Institutions

Speakers

 Atta Behfar, MD, PhD, Mayo Clinic

 Joshua M. Hare, MD, FACC, FAHA, University of Miami School of Medicine

4:00p - 5:00p  -Conference Room 1-2

Concurrent Session

Innovation Showcase

Biobanking Challenges and Strategies for Developing Cell-based Biologics Towards Clinical and Commercialization (supported by Fisher BioServices)

Moderator

 Dan O'Donnell, Fisher BioServices

Speakers

 Ian McNiece, PhD, MD Anderson Cancer Center

 Mary Pat Moyer, PhD, INCELL Corporation

4:00p - 5:00p  -Conference Room 3-4

Concurrent Session

Reg Med Capital Conference

State of the Public Markets for RegMed Companies

Speaker

 Michael D. West, PhD, BioTime, Inc.

 Henry McCusker, Scimitar Equity

4:00p - 5:00p  -Conference Room 13-14

Concurrent Session

Regenerative Services & Restorative Medicine

Clinicians Guide to Avoiding Compliance Issues with the FDA and FTC

Moderator

 R. Lee Buckler, BEd, LLB

Speaker

 Randy J. Prebula, Hogan Lovells US LLP

 Shane A. Shapiro, MD, RMSK, Mayo Clinic College of Medicine

4:00p - 5:00p  -Conference Room 17-18

Track Keynote

Hot Topics & Future Trends

Regenerative Medicine for Aging: Making Rejuvenation Comprehensive, not Cosmetic

Presenter

 Aubrey de Grey, PhD, SENS Foundation

5:00p - 6:30p  -Salon G-M

Exhibits / Posters Reception

Exhibitor Networking Reception & Poster Viewing with Presenters Present

Poster Presenters will be present to share about their posters, and judges will review at this time.

6:30p - 7:30p  -Salon E Foyer

Reception

Stem Cell Action Awards Pre-Dinner Reception (Sponsored by Cord Blood Registry)

A ticket is required to attend this event.  Tickets for this reception and the Stem Cell Action Awards are available for $125.00 per person.  They can be purchased online through our registration system, or onsite at the conference at the Registration Desk, up to 12:00 noon on Wednesday, December 3, 2014.

7:30p - 9:30p  -Salon E-F

Stem Cell Action Awards Gala Dinner

A ticket is required to attend this event.  Tickets are $125.00 per person, and can be purchased
on line through our reservation system, or at the Registration Desk on site at the conference by NOON on Wednesday, December 3, 2014.

Thursday, December 4, 2014

7:15a - 7:00p  -Registration 2

Attendee Registration

7:15a - 8:15a  -Salon G-M

Networking Breakfast

8:15a - 8:30a  -Salon E-F

Opening Remarks – Special Announcement from Conquer Paralysis Now

Moderator

 Bernard F. Siegel, JD, Genetics Policy Institute

Speaker

 Ida Cahill, Conquer Paralysis Now

 Sheryl Sculley, City of San Antonio

8:30a - 9:00a  -Salon E-F

Plenary Keynote

The Expanding Universe of CRISPR and Gene Editing

Presenter

 George M. Church, PhD, Harvard Medical School and MIT Health Sciences and Technology

9:00a - 10:00a  -Salon A-B

Panel Discussion

Discovery

Utilizing Stem Cells in the Effective Treatment of Heart Disease

Moderator

 John P. Cooke, MD, PhD, Houston Methodist Research Institute

Speakers

 Atta Behfar, MD, PhD, Mayo Clinic

 Karl-Henrik Grinnemo, MD, Karolinska Institutet

 Joshua M. Hare, MD, FACC, FAHA, University of Miami School of Medicine

9:00a - 10:00a  -Salon C-D

Panel Discussion

Translation & Clinical Trials

Global Strategies – Finding Common Ground

Moderator

 Michael N. Druckman, Hogan Lovells US LLP

Speakers

 Chris Mason, MBBS, PhD, FRCS, University College London

 Michael H. May, PhD, Centre for Commercialization of Regenerative Medicine (CCRM)

 Avi Treves, PhD, Sheba Medical Center

9:00a - 10:00a  -Conference Room 1-2

Concurrent Session

Innovation Showcase

BioFabrication: Advanced Manufacturing Technologies for Tissue Engineering

Moderator

 Joo L. Ong, PhD, The University of Texas at San Antonio (UTSA)

Speakers

 Julie G. Allickson, PhD, Wake Forest Institute for Regenerative Medicine

 Teja Guda, PhD, University of Texas at San Antonio

 Jian Ling, PhD, Southwest Research Institute

9:00a - 10:00a  -Conference Room 3-4

Concurrent Session

Reg Med Capital Conference

Company Presentations – Session 2

Speakers

 Robert J. Palay, Cellular Dynamics International

 Greg Schiffman, StemCells, Inc.

9:00a - 10:00a  -Conference Room 13-14

Track Keynote

Regenerative Services & Restorative Medicine

Fat Grafts: From a Challenging Past to an Innovative Present, and into a Revolutionary Future

Presenter

 Sydney R. Coleman, MD, Tribeca Plastic Surgery

9:00a - 10:00a  -Conference Room 17-18

Panel Discussion

Hot Topics & Future Trends

Building a Regional Innovation Ecosystem to Foster Regenerative Medicine and Life Science Companies

Building a Regional Innovation Ecosystem to Foster the Growth of Regenerative Medicine and Other Life Science Companies

Creative biomedical research does not arise in an intellectual vacuum, nor do innovative discoveries with very promising commercial potential automatically result in new products or services. There needs to be an “innovation ecosystem” that drives discovery and nurtures novel findings into the patient marketplace. First class research, sophisticated technology transfer personnel, experienced entrepreneurs, creation of incubator facilities, availability of capital, and supportive public agencies are just some of the elements that are required in an innovative environment. This panel will define and describe such an ecosystem in San Antonio which may serve as a model for other cities and regions around the country.

Moderator

 Kenneth P. Trevett, JD, Texas Biomedical Research Institute

Speakers

 Ed Davis, San Antonio Economic Development Corporation

 Randy Goldsmith, PhD, The Texas Technology Development Center

 John Kerr, Texas Next Capital

 Ann Stevens, BioMed SA

10:00a - 10:30a  -Salon G-M

Break

Morning Break – Exhibits Open

10:30a - 12:00p  -Salon A-B

Concurrent Session

Discovery

The Science of Gene Editing

Moderator

 Eric Ostertag, MD, PhD, Transposagen

Speakers

 George M. Church, PhD, Harvard Medical School and MIT Health Sciences & Technology

 Hiromitsu Nakauchi, MD, PhD, Centre for Stem Cell Biology and Regenerative Medicine Institute of Medical Science

10:30a - 12:00p  -Salon C-D

Concurrent Session

Translation & Clinical Trials

Banking on Cord Blood Stem Cells: Is the Future Here? (supported by Cord Blood Registry)

Panel discussion will provide updated information regarding preclinical and clinical experience with autologous stem cells for neurological applications and other potential future uses. Learning objectives to include:

  • To analyze the potential role of cord blood stem cells as a promising therapeutic tool in the development of innovative treatments
  • To explain the current usage and therapeutic potential of cord blood stem cells
  • To describe the use of autologous cord blood stem cells in clinical regenerative medicine applications
  • To review approaches for reprogramming cord blood cells into induced pluripotent stem cells and potential applications in regenerative medicine.

Moderator

 Heather Brown, MS, LCGC, Cord Blood Registry

Speakers

 Charles S. Cox, MD, UT Health Science Center at Houston

 Mahendra Rao, MD, PhD, Q Therapeutics & NYSCF

 Frances Verter, PhD, Parents Guide to Cord Blood Foundation

10:30a - 12:00p  -Conference Room 1-2

Concurrent Session

Innovation Showcase

Selecting the Right CRO/CMO Partner (supported by Bioscience Technology)

Moderator

 Tim Studt, Advantage Media Group

Speakers

 Robert E. Margolin, MBS, MBA, Cognate BioServices, Inc.

 Mary Pat Moyer, PhD, INCELL Corporation

10:30a - 12:00p  -Conference Room 3-4

Concurrent Session

Reg Med Capital Conference

Company Presentations – Session 3

Moderator

 Connie Koch Farrell, Keiretsu Forum Southern CA, LLA

Speakers

 Connie Koch Harrell, Keiretsu Forum Southern California, LLA

 R. Lee Buckler BEd, LLB, RepliCel Life Sciences, Inc.

 Bob Hutchens, StemBioSys, Inc.

 Gary Sams, PhD, Progenitor Life Sciences, LLC

10:30a - 12:00p  -Conference Room 13-14

Concurrent Session

Regenerative Services & Restorative Medicine

Cell Standardization for Clinical Practice (supported by AABB)

Moderator

 Uplaksh Kumar, PhD, AABB

Speakers

 Jim Beltzer, PhD, Terumo BCT

 James Lovgren, ORIG3N

 Madhusudan V. Peshwa, PhD, MaxCyte, Inc.

10:30a - 12:00p  -Conference Room 17-18

Concurrent Session

Hot Topics & Future Trends

Reproducibility and Rigor in Research: What We have Learned from STAP Debacle

The panel members’ roles as a ‘PI’, an ‘Editor’, and a ‘Public Advocate’ will serve as a basis for discussing the ethics of publication in regenerative medicine and in particular when the interpretation and acceptance of that work is called into question. Landmark examples will be used to kick off the discussion concerning the responsibilities of the laboratories, editors and the scientific community, but the panel also anticipates a lively, constructive discussion with the audience.

Moderator

 Graham Parker, PhD, Wayne State University School of Medicine

Speakers

 Jeanne F. Loring, PhD, The Scripps Research Institute

 Ivan Oransky, MD, MedPage Today, Retraction Watch

12:00p-1:30p  -Salon E Foyer

Pre-Paid Box Lunch Pick-Up

You may order a boxed lunch in ADVANCE of the conference for $20.00.
This can be done through the registration system.   A limited number may be
available for payment onsite.

12:10p - 1:30p  -Salon E-F

Symposia

Navigating the Two Valleys of Death: Transforming Scientific Advances into Medical Breakthroughs (Symposium sponsored by BioBridge Global

From a societal return perspective, the ultimate payoff from investments into basic biomedical research comes in the form of the medical breakthroughs enabled by it. It would be unrealistic to expect all basic biomedical research to yield inventions with industrial applicability. Nonetheless, most breakthroughs in our understanding of the molecular cell biology basis of human disease eventually find their way to patients in the form of medical interventions (drugs, biologics, medical devices, cell therapies and/or procedures) physicians can prescribe on behalf of a patient in need. Sean Thompson begins this session by providing an overview of the reality of “bench to bedside”. He explains how the tangible results of basic biomedical research move along the biomedical product development pathway, introduces the notion of the “two valleys of death” that exist along this pathway, and suggests how blood and tissue centers and other non-profits may help overcome these two obstacles to successful biomedical product development. The following subject matter expert presenters in the session will address discrete segments of the product development pathway. Marie Csete from the Huntington Medical Research Institutes will provide the perspective of a center where scientific advances/discoveries are first made, and suggest ways to optimize the translation of scientific advancements to medical breakthroughs. Next, Steve Schmid from Vivo Biosciences will discuss the importance of providing proof-of-concept data sufficient to encourage startup investors and later existing biomedical companies to in-license biomedical technologies and invest the resources required to transform the technology into marketable product. Next, Randy Goldsmith will address the non-technology aspects of biomedical opportunities and discuss the importance of presenting an Investor-Ready investment opportunity by showing how a given product opportunity can be transformed into thriving business. Finally, John Kerr of TexasNext Capital will speak from the perspective of a private equity/venture capital investor tasked with carefully choosing companies in which to invest fund resources to earn an appropriate risk-adjusted return for investors.

Moderator

 Sean Thompson, MS, MBA, CLP, BioBridge Global

Speakers

 Marie Csete, MD, PhD, Huntington Medical Research Institute

 Randy Goldsmith, PhD, The Texas Technology Development Center

 John Kerr, Texas Next Capital

 Steven M. Schmid, PhD, Vivo Biosciences

12:10p - 1:30p  -Salon A-B

Symposia

Japan Symposium: Mass Culture System, QC, 3D Construction, Freezing System and Delivery System

Moderator

 Takashi Asada, PhD, Kyoto University

Speakers

 Tomoki Aoyama MD, PhD, Kyoto University

 Kouichi Hasegawa, PhD, Kyoto University

 Masanari Kitagawa, PhD, Takara Bio Inc.

 Koji Kuchiishi, Cyfuse Biomedical K.K.

 Mikiyoshi Nakamichi, Tamai-Kasei. K.K.

 Norio Nakatsuji, DSc, Institute for Integrated Cell-Material Science (iCeMS), Kyoto University

 Taito Nishino, Nissan Chemical Industries, Ltd.

 Yasuhiro Suzue, Kaneka Corporation

 Tomomi Yamazaki, NEDO

 Chikafumi Yokoyama, PhD, ReproCELL, Inc.

12:10p - 1:30p  -Salon C-D

Workshop

7th Annual IRB, ESCRO and SCRO Workshop – Meeting the Institutional Oversight Challenges to Stem Cell Research

This year’s Workshop will focus on how institutional oversight of stem cell research has evolved in response to the many advances in stem cell science and in light of the absence of overriding federal regulation and the diversity of state requirements.
The session will include:
·        A brief review of how funding requirements, voluntary professional guidance, state-based initiatives, and human subject regulations are shaping policies and procedures for stem cell research oversight.
·        Case studies that illustrate how the nature of research undertaken and the differences in the regulations, funding requirements and local attitudes have shaped the role of IRB/ESCRO/SCROs in different jurisdictions.
·        Interactive discussion driven by participants and guided by case questions.  Bring your questions and burning issues!

Speakers

 Melinda Abelman, MSc, CIP, Partners HealthCare System

 Amy Wilkerson, The Rockefeller University

1:30p - 2:30p  -Salon A-B

Concurrent Session

Discovery

Stem Cells for Disease Modeling

  • Disease-modeling: technology development and use
    –Disease-specific stem cells: progress
    –Disease-specific stem cells: hurdles
    –Attrition rate indicators
  • Disease-modeling: case studies
    –Applications in cardiovascular diseases
    –Applications in diabetes and its complications
    –Applications in neurologicaldisorders
  • Deployment of stem cells for research: Pharma & CROs
    –Toxicological applications: cardiomyocytes and QT interval
    –Trends in strategic alliances
    –CRO services as a proxy for technology maturity; cost considerations

Moderator

 Alain Vertes, PhD, NxR Biotechnologies

Speakers

 Timothy J. Nelson, MD, PhD, Mayo Clinic

 Fernando Pitossi, PhD, Leloir Institute

 Gary D. Smith, PhD, HCLD, University of Michigan

1:30p - 2:30p  -Salon C-D

Concurrent Session

Translation & Clinical Trials

Public Policy and Ethics – Challenges and Solutions

Moderator

 Alan Jakimo, JD, Sidley-Austin, LLP

Speakers

 Timo Faltus, Translational Centre for Regenerative Medicine (TRM)

 Kirstin R.W. Matthews, PhD, Rice University

 Beth Roxland, JD, M.Bioethics, Johnson & Johnson, Inc.

1:30p - 2:30p  -Conference Room 1-2

Concurrent Session

Innovation Showcase

Storage Technology Trends (supported by Bioscience Technology)

Moderator

 Christina Jakubowski, Bioscience Technology

Speakers

 Michael C. Hiles, PhD, Cook Biotechnology Inc.

 Joe LaPorte, Panasonic Healthcare Corporation of North America

1:30p - 2:30p  -Conference Room 3-4

Panel Discussion

Reg Med Capital Conference

Innovative Ways to Fund Innovative Companies: Power to the People – supported by Polliwog Regenerative Medicine Fund

Moderator

 Brock C. Reeve, PhD, Harvard Stem Cell Institute

Speakers

 Kurt H. Kruger, WR Hambrect + Co.

 Dan Gincel, PhD, MD Stem Cell Research Fund

 Michael H. May, PhD, Centre for Commercialization of Regenerative Medicine (CCRM)

 Brock C. Reeve, Harvard Stem Cell Institute, Polliwog Regenerative Medicine Fund

1:30p - 2:30p  -Conference Room 13-14

Concurrent Session

Regenerative Services & Restorative Medicine

RegMed Solutions for Orthopedic Injuries and Extremity Regeneration

Moderator

 William L. Murphy, PhD, University of Wisconsin

Speaker

 Chris Rathbone, PhD, United States Army Institute of Surgical Research

 Dmitry Tuder, MD, San Antonio Military Medical Center

1:30p - 2:30p  -Conference Room 17-18

Concurrent Session

Hot Topics & Future Trends

Eureka! Now What? (supported by Hogan Lovells)

You’ve made the discovery and identified clinical applications, but now what?  It’s time to take the technology out of the lab.  This Post-Discovery 101 session is designed to provide overview and insight into such areas as technology transfer options and the basics of FDA regulation and terminology.  Come gain insight on the steps to commercialization and branding with this practical and informative global view of a critical area of innovation development.

Speakers

 Jerry Phillips, RPh, Drug Safety Institute, inc.

 Michael P. Levinson, MD, JD, Hogan Lovells

 Maria A. Vodicka, PhD, Hogan Lovells

2:30p - 3:30p  -Salon A-B

Concurrent Session

Discovery

Discovering the Root Cause of Disease

Speaker

 Paula K. Shireman, MD, University of Texas Health Science Center San Antonio South Texas Veterans Health Care System

2:30p - 3:30p  -Salon C-D

Track Keynote

Translation & Clinical Trials

IPSC’s for Drug Discovery

Presenter

 Mahendra Rao, PhD, Q Therapeutics and The New York Stem Cell Foundation

2:30p - 3:30p  -Conference Room 1-2

Concurrent Session

Innovation Showcase

Cell Culture: Finding the Right Formulas for Your Laboratory

Speakers

 Taito Nishino, Nissan Chemical Industries, Ltd.

 Rae D. Record Ritchie, PhD, Cook Biotech, Inc.

 Martha S. Rook, PhD, EMD Millipore Corporation

2:30p - 3:30p  -Conference Room 3-4

Concurrent Session

Reg Med Capital Conference

Future Trends: Presented by Leading Investment Banks

Speakers

 Rick Blume, Excel Venture Management

 Michael Meyers, MPH, T.R. Winston & Company

2:30p - 3:30p  -Conference Room 17-18

Concurrent Session

Regenerative Services & Restorative Medicine

Wound Healing and Restorative Medicine

Moderator

 Michael R. Davis, MD, FACS, US Army Institute of Surgical Research

Speaker

 Rodney Chan, MD, FACS, FRSCS, San Antonio Military Medical Center and Uniformed Services University of the Health Sciences

 Robert J. Christy, PhD, US Army Institute of Surgical Research

2:30p - 3:30p  -Conference Room 17-18

Concurrent Session

Hot Topics & Future Trends

Growing Whole Organs

Moderator

 Tyler Emerson, New Organ

Speakers

 Julie G. Allickson, PhD, Wake Forest Institute for Regenerative Medicine

 Hiromitsu Nakauchi, MD, PhD, Centre for Stem Cell Biology and Regenerative Medicine Institute of Medical Science

 Doris A. Taylor, PhD, FAHA, FACC, Texas Heart Institute at St. Luke's Episcopal Hospital

3:30p - 4:00p  -Salon G-M

Afternoon Break – Exhibits Open

4:00p - 5:00p  -Salon E-F

Panel Discussion

Huntington’s Disease: Unlocking the Mystery and Finding a Cure

Moderator

 Jan A. Nolta, PhD, University of California, Davis

Speakers

 Katie Jackson, Help 4 HD International, Inc.

 C. Randal Mills, PhD, California Institute for Regenerative Medicine (CIRM)

 Vicki L. Wheelock, MD, University of California, Davis

5:00p - 7:00p  -Salon G-M

Exhibits / Posters Reception

Exhibitor Networking Reception & Poster Viewing with Presenters Present

Poster Presenters will be present to share about their posters, and judges will review at this time.

5:30p - 7:00p  -Salon C-D

Symposia

Terumo BCT “Hands-On” Workshop & Presentation: Requirements for a Cell Therapy Facility: Expect the Unexpected

Sponsored Session and Reception — Hands-on Information Sessions exploring:
Immunotherapy, Gene Therapy, Cell Therapy & Manual vs. Automated Comparison

Speakers

 Jim Beltzer, PhD, Terumo BCT

 Patrick J. Hanley, PhD, Children's National and George Washington University

7:00p - 8:30p  -Conference Room 17-18

Symposia

Symposia – Lectures on Single Cell Analysis Sponsored by Fluidigm

Sponsored Session and Reception

Speakers

 Brian P. Hermann, PhD, University of Texas at San Antonio

 David Knapp, British Columbia Cancer Agency

 Ryan L. McCarthy, PhD, The University of Texas MD Anderson Cancer Center

Friday, December 5, 2014

8:00a - 1:00p  -Registration 2

Attendee Registration

8:00a - 9:00a  -Salon G-M

Networking Breakfast

8:00a - 12:00p  -Salon G-M

Exhibits Open

9:00a - 9:40a  -Salon E-F

Plenary Keynote

Human Eggs in Stem Cell Research and Reproduction

Presenter

 Dieter Egli, New York Stem Cell Foundation

9:00a - 10:00a  -Conference Room 3-4

Plenary Keynote

Reg Med Capital Conference

The Future of Regenerative Medicine and How to Finance it

Presenter

 Howard Leonhardt, Leonhardt Ventures

9:40a - 10:00a  -Salon E-F

Plenary Keynote

Development of Japanese Regenerative Medicine Industry

Presenter

 Takuya Yokokawa, FujiFilm

10:00a - 11:00a  -Salon A-B

Panel Discussion

Discovery

NEUROLOGICAL SOLUTIONS FOR CHRONIC MEDICAL CONDITIONS

Moderator

 Marcel M. Daadi, PhD, Texas Biomedical Research Institute

Speakers

 Erzsebet Kokovay, PhD, University of Texas Health Science Center at San Antonio

 Jeanne F. Loring, PhD, The Scripps Research Institute

 Evan Y. Snyder, MD, PhD, FAAP, Sanford-Burnham Medical Research Institute, Stem Cell Research Center

10:00a - 11:00a  -Salon C-D

Panel Discussion

Translation & Clinical Trials

Cardiovascular Clinical Trials

Moderator

 Darcy L. DiFede, University of Miami

Speakers

 John P. Cooke, MD, PhD, Houston Methodist Research Institute

 Emerson C. Perin, MD, PhD, FACC, Texas Heart Institute

 James T. Willerson, MD, The University of Texas Health Science Center, Houston

10:00a - 11:00a  -Conference Room 1-2

Panel Discussion

Innovation Showcase

Data Analysis Needs in Regenerative Medicine (supported by Bioscience Technology)

Moderator

 Tim Studt, Advantage Media

Speakers

 Michele Reilly, Turing, Inc.

 Michael Vassar, MetaMed

 James M. Watt, PhD, Eagle Medical Services, LLC

10:00a - 11:00a  -Conference Room 3-4

Panel Discussion

Reg Med Capital Conference

Company Presentations – Session 4

Speaker

 Wei "William" Cao, PhD, BM, Cellular Biomedicine Group

 Chikafumi Yokoyama, PhD, ReproCELL, Inc.

10:00a - 11:00a  -Conference Room 13-14

Panel Discussion

Regenerative Services & Restorative Medicine

Stem Cell Treatments in Sports Medicine

Speakers

 Paul S. Saenz, DO, Sports Medicine Associates

 Shane A. Shapiro, MD, RMSK, Mayo Clinic College of Medicine

10:00a - 11:00a  -Conference Room 17-18

Panel Discussion

Hot Topics & Future Trends

Academic and Commercial Opportunities in Pursuit of Longevity

Moderator

 Aubrey de Grey, PhD, SENS Foundation

Speakers

 Rochelle Buffenstein, PhD, UTHSCSA

 Xiao-Dong Chen, MD, PhD, StemBioSys, Inc.

 Matthew Scholz, Immusoft Corporation

11:00a - 11:30a  -Salon G-M

Morning Break

11:30a - 12:30p  -Salon A-B

Concurrent Session

Discovery

The Third Pillar of Pluripotency: Somatic Cell Nuclear Transfer

Moderator

 Mahendra Rao, MD, PhD, Q Therapeutics &The New York Stem Cell Foundation

Speakers

 Stephen M. W. Chang, PhD,Vice President, Research and Development, The New York Stem Cell Foundation

 Dieter Egli, PhD, New York Stem Cell Foundation Research Institute

 Aaron D. Levine, Georgia Tech

11:30a - 12:30p  -Salon C-D

Concurrent Session

Translation & Clinical Trials

The Life of a Cellular Therapeutic from Conception to Maturity as Viewed through the Lenses of Academia, Regulatory and Commercialization. (Supported by the International Society for Cellular Therapy – ISCT)

Professor A. L. Kleehall at the High and Mighty Research Institute (HMRI) has been working on developing a more sensitive bio-assay for early stage cirrhosis of the liver. In one experiment, he has been placing cirrhotic mouse livers into tissue culture with different cell lines whose metabolism is sensitive to changes in liver enzymes, notably ALT. In one of his cultures, however, he notes that in the most cirrhotic livers the cirrhosis appears to be reversing. At first he believes that he must have just mixed up the cultures, but after several repeat experiments, he notes that the particular cell line, Delta Tau Chi, seems to be interacting with the livers. On a whim, Prof. Kleehall has a pathologist friend make thin sections of the repairing livers and stain them. On microscopic examination, it is clear that Delta Tau Chi cells are invasively migrating to the areas of scar tissue. The potential of such a cell line to treat a range of patients from hepatitis C afflicted to recovered alcoholics is not lost on Prof. Kleehall, and he would like to get his new discovery into clinical application as soon as possible. In this presentation, four of Prof. Kleehall’s friends who are all active in the International Society for Cellular Therapy will describe how they bring the elements of academic strength, regulatory know-how, and a strong commercial involvement to help Prof. Kleehall bring his discovery to maturity as a therapeutic agent.

Moderator

 William E. Janssen, PhD, International Society for Cellular Therapies (ISCT)

Speakers

 Massimo Dominici, MD, International Society of Cellular Therapies (ISCT)

 Karen M. Nichols, Esq., Conkwest, Inc.

 Claudia Zylberberg, PhD, Akron Biotechnology, LLC

11:30a - 12:30p  -Conference Room 3-4

Concurrent Session

Reg Med Capital Conference

Company Presentations – Session 5

Speakers

 Jun Wang, PhD, Phycin, LLC

 Matthew Scholz, Immusoft Corporation

11:30a - 12:30p  -Conference Room 13-14

Concurrent Session

Regenerative Services & Restorative Medicine

General Regenerative Medicine

 Matthias Corbascio, MD, PhD, Karolinska University Hospital, Solna

11:30a - 12:30p  -Conference Room 17-18

Concurrent Session

Hot Topics & Future Trends

New Paths to the Final Frontier: Enabling Stem Cell Research in Space for Life on Earth (Supported by CASIS)

Moderator

 Michael S. Roberts, PhD, Center for the Advancement of Science in Space, Inc.

Speakers

 Carl Gregory, PhD, Texas A&M Institute for Regenerative Medicine

 Mary Kearns-Jonker, PhD, Loma Linda University School of Medicine

 Abba C. Zubair MD, PhD, Mayo Clinic Florida

12:30p - 2:00p  -Salon G-M

Pre-paid Box Lunch Pick-Up

You may order a boxed lunch in ADVANCE of the conference for $20.00.
This can be done through the registration system.   A limited number may be
available for payment onsite.

12:45p - 2:00p  -Salon E-F

Symposia

Bridging the Valleys of Death: How Blood Banks and Other Non-profits Can Help Advance the Field of Cell-Based Therapies/Regenerative Medicine (supported by BioBridge Global)

The translational pipeline is loaded with bumpy roads, valleys, and treacherous cliffs (and occasionally some smooth sailing). This session presents experts at various stages along that road, to discuss their experience in developing new lines of business in the regenerative medicine space, and their strategies for smooth progress through their developmental programs. The first two speakers come from the blood industry, the founding industry of cell therapies, though not yet in the mainstream of the new wave of stem cell and tissue engineering based therapies. Linda Myers will discuss how the South Texas Blood and Tissue Center developed a strategy to enter mainstream regenerative medicine via BioBridge Global. Lisa Shaffer will discuss the strengths blood centers generally bring to regenerative medicine research and clinical trials, and the efforts of a professional society to develop a rational entrance into new businesses for blood centers.   James Trager of Dendreon has seen the entire developmental pipeline of a dendritic cell therapy for prostate cancer, including many lessons for those in the process of developing cell-based therapies. Bruce Levine from Penn will present the academic perspective on the transition from discovery science in academics to the clinical trials stages with promising therapies for cancers, chimeric antigen receptor T cells. This panel promises both cautionary tales for all scientists in regenerative medicine, as well as models for inspired decision making in the development of a new industry.

Moderator

 Marie Csete, MD, PhD, Huntington Medical Research Institute

Speakers

 Bruce Levine, PhD, University of Pennsylvania

 Linda Myers, ASCP, MT, SBB, CQA (ASQ), BioBridge Global

 Lisa Shaffer, Blood Centers of Amerca (BCA)

 James B. Trager, PhD, Dendreon Corporation

2:00p - 3:00p  -Salon A-B

Concurrent Session

Discovery

Stem Cells and Mental Health

Moderator

 George Perry, PhD, The University of Texas at San Antonio

Speakers

 Daniel J. Lodge, PhD, University of Texas Health Science Center

 Evan Y. Snyder, MD, PhD, FAAP, Sanford-Burnham Medical Research Institute, Stem Cell Research Center

2:00p - 3:00p  -Salon C-D

Concurrent Session

Translation & Clinical Trials

Stem Cell Registries and Banks: Advancing Regulation and Standardization

Moderator

 Rosario Isasi, MD, MPH, McGill University

Speakers

 Rosario Isasi, JD, MPH, McGill University and Genome Quebec Innovation Centre

 Andreas Kurtz, PhD, Charite Universitatsmedizin Berlin, Germany

 Tenneille Ludwig, PhD, WiCell

 Mahendra Rao, MD, PhD, Q Therapeutics & NYSCF

 Zachary Resch, PhD, Mayo Clinic

2:00p - 3:00p  -Conference Room 3-4

Concurrent Session

Reg Med Capital Conference

Company Presentations – Session 6

 Howard Leonhardt, Leonhardt Ventures

 Wei "William" Cao, PhD, BM, Cellular Biomedicine Group

2:00p - 3:00p  -Conference Room 13-14

Concurrent Session

Regenerative Services & Restorative Medicine

Consumer Guide to Stem Cell Therapies: Questions to Ask Before Committing to Treatment

Moderator

 R. Lee Buckler, BEd, LLB, Cell Therapy Group

Speakers

 Steven A. Davis, MD, StemBioSys, Inc.

 Karen M. Nichols, Esq., Conkwest, Inc.

2:00p - 3:00p  -Conference Room 17-18

Concurrent Session

Hot Topics & Future Trends

NASA: Stem Cells in Space

Moderator

 Jeffrey D. Smith, PhD, NASA Ames Research Center

Speakers

 Eduardo Almeida, PhD, NASA Ames Research Center

 S. Keith Chapes, PhD, MPH, Kansas State University

 David L. Tomko, PhD, NASA Headquarters

 David Wolf, MD, Former NASA Astronaut

3:00p - 4:00p  -Salon A-B

Concurrent Session

Discovery

Stem Cells for Oral Health

Moderator

 Christi A. Walter, PhD, The University of Texas Health Science Center, San Antonio

Speakers

 Xiao-Dong Chen, MD, PhD, StemBioSys, Inc.

 Anibal R. Diogenes, DDS, MS, PhD, University of Texas Health Science Center

3:00p - 4:00p  -Salon C-D

Concurrent Session

Translation & Clinical Trials

Establishing Best Practices for the Production of High Quality Stem Cell Lines (supported by Coriell)

Moderator

 Steven J. Madore, PhD, Coriell Institute for Medical Research

Speakers

 Stephen M. W. Chang, PhD,Vice President, Research and Development, The New York Stem Cell Foundation

 Karen Dyer Montgomery, PhD, FACMG, WiCell Research Institute

 Cristian A. Pérez, PhD, Coriell Institute for Medical Research

 Thomas J. Novak, PhD, Cellular Dynamics International

3:00p - 4:00p  -Conference Room 1-2

Concurrent Session

Innovation Showcase

Reimbursement and Insurance for RegMed and Cell Banking Business Models

Speakers

 Nic Anderson, MA, MBA, Medicial Technology Analayst and HEOR Consultant

 Andrew Catton, Miller Insurance Services, LLP

 Amnon Pelz, Taburit, Cord Blood - Stem Cell Solutions

3:00p - 4:00p  -Conference Room 13-14

Track Keynote

Regenerative Services & Restorative Medicine

Designing and Building Targeted Immunity from Patient’s Own Cells: Treating Untreatable Cancers or HIV

Presenter

 Bruce Levine, PhD, University of Pennsylvania

3:00p - 4:00p  -Conference Room 17-18

Concurrent Session

Hot Topics & Future Trends

Effective Patient Advocacy — The Power of Commitment

Moderator

 Bernard F. Siegel, JD, Genetics Policy Institute

Speakers

 David L. Bales, Texans for Stem Cell Research

 Alan Fernandez, Genetics Policy Institute

 Tory Williams, AIM

4:00p - 4:15p  -Salon E Foyer

Afternoon Break

4:15p - 5:30p  -Salon E-F

Panel Discussion

Patient Groups, Foundations & Venture Philanthropy- Crucial Parties Funding Research and Delivering Therapies to Market and Patients

RegMed Capital Conference and Philanthropy/Advocacy Discussion

Moderator

 Christian Braemer, Benefunder

 Angela V. Choquette, CAP, Merrill Lynch Trust Company

 Hemai Parthasarathy, PhD, Breakout Labs, The Peter Thiel Foundation

 Bernard Siegel, JD, Genetics Policy Institute

 F. Michael Wood, Jr., CFP, CIMA, ARPC, Merrill Lynch

5:30p - 6:30p  -Salon E Foyer

Closing Reception!